240 related articles for article (PubMed ID: 2151405)
1. [GnRH-analogs in the therapy of uterine myomatosis].
Wieacker P; Geisthövel F; Adelberger V; Breckwoldt M
Ther Umsch; 1990 Dec; 47(12):951-7. PubMed ID: 2151405
[TBL] [Abstract][Full Text] [Related]
2. Gonadotropin-releasing hormone (GnRH) action on uterine leiomyomata is not mediated by uterine GnRH receptors.
Neuman M; Langer R; Golan A; Bukovsky I; Caspi E; Koch Y
Fertil Steril; 1991 Aug; 56(2):364-6. PubMed ID: 1649060
[No Abstract] [Full Text] [Related]
3. Long-term follow-up of patients with uterine fibroids after treatment with the LHRH agonist buserelin.
Matta WH; Shaw RW; Nye M
Br J Obstet Gynaecol; 1989 Feb; 96(2):200-6. PubMed ID: 2495020
[TBL] [Abstract][Full Text] [Related]
4. Pre-operative GnRH analogue therapy before hysterectomy or myomectomy for uterine fibroids.
Lethaby A; Vollenhoven B; Sowter M
Cochrane Database Syst Rev; 2000; (2):CD000547. PubMed ID: 10796723
[TBL] [Abstract][Full Text] [Related]
5. Pre-operative GnRH analogue therapy before hysterectomy or myomectomy for uterine fibroids.
Lethaby A; Vollenhoven B; Sowter M
Cochrane Database Syst Rev; 2001; (2):CD000547. PubMed ID: 11405968
[TBL] [Abstract][Full Text] [Related]
6. Treatment of uterine fibroids with agonist analogs of gonadotropin-releasing hormone.
Kessel B; Liu J; Mortola J; Berga S; Yen SS
Fertil Steril; 1988 Mar; 49(3):538-41. PubMed ID: 3277869
[TBL] [Abstract][Full Text] [Related]
7. An evaluation of the effect of gonadotropin-releasing hormone analogs and medroxyprogesterone acetate on uterine leiomyomata volume by magnetic resonance imaging: a prospective, randomized, double blind, placebo-controlled, crossover trial.
Carr BR; Marshburn PB; Weatherall PT; Bradshaw KD; Breslau NA; Byrd W; Roark M; Steinkampf MP
J Clin Endocrinol Metab; 1993 May; 76(5):1217-23. PubMed ID: 8496313
[TBL] [Abstract][Full Text] [Related]
8. Pre-surgical treatment of uterine myomas with LH-RH agonists.
D'Addato F; Repinto A; Andreoli C
Clin Exp Obstet Gynecol; 1992; 19(1):45-50. PubMed ID: 1535032
[TBL] [Abstract][Full Text] [Related]
9. Toward removing uterine fibroids without surgery: subcutaneous infusion of a luteinizing hormone-releasing hormone agonist commencing in the luteal phase.
Healy DL; Lawson SR; Abbott M; Baird DT; Fraser HM
J Clin Endocrinol Metab; 1986 Sep; 63(3):619-25. PubMed ID: 3090092
[TBL] [Abstract][Full Text] [Related]
10. Hormonal therapy before surgical treatment for uterine leiomyomas.
Moghissi KS
Surg Gynecol Obstet; 1991 Jun; 172(6):497-502. PubMed ID: 1827931
[TBL] [Abstract][Full Text] [Related]
11. Uterine leiomyomata and sterility: therapy with gonadotropin-releasing hormone agonists and leiomyomectomy.
Kuhlmann M; Gärtner A; Schindler EM; Regidor PA; Bühler K; Schindler AE
Gynecol Endocrinol; 1997 Jun; 11(3):169-74. PubMed ID: 9209897
[TBL] [Abstract][Full Text] [Related]
12. Treatment of uterine fibroids with implants of gonadotropin-releasing hormone agonist: assessment by hysterography.
Donnez J; Schrurs B; Gillerot S; Sandow J; Clerckx F
Fertil Steril; 1989 Jun; 51(6):947-50. PubMed ID: 2498131
[TBL] [Abstract][Full Text] [Related]
13. Triptorelin to prevent hysterectomy in patients with leiomyomas.
van Leusden HA
Lancet; 1988 Aug; 2(8609):508. PubMed ID: 2900426
[No Abstract] [Full Text] [Related]
14. A prospective, randomized trial of gonadotropin-releasing hormone agonist plus estrogen-progestin or progestin "add-back" regimens for women with leiomyomata uteri.
Friedman AJ; Daly M; Juneau-Norcross M; Rein MS; Fine C; Gleason R; Leboff M
J Clin Endocrinol Metab; 1993 Jun; 76(6):1439-45. PubMed ID: 8501148
[TBL] [Abstract][Full Text] [Related]
15. Treatment of uterine fibroid with triptorelin before hysterectomy.
Loong EP; Lo KW
Chin Med J (Engl); 1998 Jan; 111(1):67-70. PubMed ID: 10322658
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of a gonadotropin-releasing hormone agonist in the treatment of uterine leiomyomata: long-term follow-up.
Letterie GS; Coddington CC; Winkel CA; Shawker TH; Loriaux DL; Collins RL
Fertil Steril; 1989 Jun; 51(6):951-6. PubMed ID: 2498132
[TBL] [Abstract][Full Text] [Related]
17. Gonadotropin-releasing hormone specific binding sites in uterine leiomyomata.
Wiznitzer A; Marbach M; Hazum E; Insler V; Sharoni Y; Levy J
Biochem Biophys Res Commun; 1988 May; 152(3):1326-31. PubMed ID: 2837183
[TBL] [Abstract][Full Text] [Related]
18. Subcutaneous injection or infusion of gonadotropin releasing-hormone agonist buserelin in the treatment of enlarged uteri harboring leiomyomata.
Franssen AM; Willemsen WN; Corbey RS; Doesburg WH; van 't Veen AJ; Rolland R
Eur J Obstet Gynecol Reprod Biol; 1991 Jul; 40(3):221-8. PubMed ID: 1908799
[TBL] [Abstract][Full Text] [Related]
19. Treatment of leiomyomata with intranasal or subcutaneous leuprolide, a gonadotropin-releasing hormone agonist.
Friedman AJ; Barbieri RL; Benacerraf BR; Schiff I
Fertil Steril; 1987 Oct; 48(4):560-4. PubMed ID: 3115833
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of LHRH analogue action in uterine fibroids.
Shaw RW
Horm Res; 1989; 32 Suppl 1():150-3. PubMed ID: 2533145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]